Early cannabinoid exposure as a source of vulnerability to opiate addiction: A model in laboratory rodents. by Rodríguez de Fonseca, Fernando & Navarro, Miguel
The Spanish Journal ol Psychology Copyright 1998 by The Spaiúsh Jourual of Psychology
[998,Vol. 1. No, 1,39-58 1138-7416
Early Cannabinoid Exposure as a Source of Vulnerability to
Opiate Addiction: A Model in Laboratory Rodents
Miguel Navarro* and Fernando Rodríguez de Fonseca
Complutense University of Madrid
Recent findings have identified an endogcnous brain system mediating ihe actions of
cannab/s sol/ro preparations. This system includes Ihe brain cannabinoid receptor (GB-
1) and iís endogenous ligands anandamide aud 2-arachidonoyl-glycerol. The endogenous
cannabinoid system is not only present in the adult brain, huí is also active at early stages
of brain development. Studies developed at our laboratory have revealed thai maternal
exposure to psychoactive cannabinoid resulis in neuro-developmental alterations. A model
is proposed in which early A9-tetrahydrocannabinol (THC) exposure during criticaldcvclopmental periods results in permanení alterations in brain fuoction by either the
stimulation of CB-I receptors present during the development, or by the alterations in
maternal glucocorticoid secrerion. Thosc alterations will be revealed in adulthood afíer
challenges either with drogs (le. opiates) or with environmental stressors (le. nove]ty).
They wfll include a modifled patrera of neuro-chemical, endocdne, and behavioral responses
that might lead ultimately lo inadaptation and vulnerability to opiate abuse.
K~.y vvords: mt, cannobino/ds, perinatal exposure, /,ehav/or op/ates, condit/oning, A CTH,
corticosterone, vulnerabitiiy
En los ultimos años se ha logrado identificar un sistema endógeno que media las acciones
de los principios activos del cannabis sativa. Este sistema está compuesto por el receptor
para cannabinoides cerebral (CB-1>, y sus ligandos endógenos, la anandamida y el 2-
araquídonilglicerol. El sistema cannabinoide endógeno está activo en el cerebro adulto,
participando también en el desarrollo cerebral. Los estudios desarrollados en nuestro
laboratorio han demostrado que la exposición maternal durante la gestación y la lactancia
a compuestos activos en el receptor CB-1 conducen a alteraciones en el desarrollo
cerebral. En este trabajo se propone un modelo en el cual la exposición durante periodos
críticos del desarrollo a J9-tetrahydrocannabinol (THC), el principal cannabinoide psicoactivo
del cannabis sativa, induce cambios permanentes en la función cerebral, bien mediante
la activación de los receptores CB-1 presentes durante edades tempranas del desarrollo,
o bien mediante la alteración de la secreción maternal de glucocorticoides. Estas
alteraciones se manifiestan en la edad adulta tras la exposición a desafíos adaptativos,
como el tratamiento con drogas de abuso (opiáceos> o el estrés medioambiental (novedad,
etc.), que inducen respuestas neuroquimicashormonales y comportamentales anómalas,
que se manifiestan como una mayor vulnerabilidad a la adicción.
Palabras clave: rata, cannabinoides, exposicion perinata¿ conducta, condicionamiento,
morfina, glucocorticoides.
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The use of Cannabis sativa preparaíions (hashish,
marijuana) has a long history, from folkloric use In anciení
times, [o Ihe wide~spread recreational use in Ihe twentieth
century (Mechoulam, 1986). However, it is only within the
past 30 years [bat researchers have begun to understand tbe
biological basis of te pharmacological effects of cannabis.
Moreover, te last lO years have been crucial for identifying
te neural substraíes underlying cannabis aetions in the brain
(see Table 1, section A). Since Ihe seminal discovery of the
cannabinoids, the psychoactive compounds of cannabis, with
the isolation of A9-tetrahydrocannabinol (THC) as the main
cannabinoid (Gaoni & Mechoulam, 1964), extraordinary
advances have led ¡o the syntbesis of psychoactive
cannabimimetic agents (Dewey, 1986; Mechoulam et al.,
1987), and to Ihe identification of an endogeneus system
mediating the neuro-phannacological actions of cannabinoids.
This endogenous system, Ihe endocannabinoid systeín, is
composed of the CE- 1 brain cannabinoid receptor (Devane,
Dysarz, Johnson, Melvin, & Howletí, 1988; Hcrkenham et
aL, 1990; Matsuda, Lolait, Hrownstein, Young, & Bonner,
1990), and several brain constituents that have been proposed
as endogenous Iigands for the CB.-¡ receptor, including
Table 1
A. Major Advances in Cannabis Research. B. Contributions
anandamide (Devane el al., 1992; Di Marzo et al., 1994) aud
2-arachydonoylglycerol (Mechoulam et al., 1995; Stella et
al., 1997). Surprisingly, the CB-¡ cannabinoid receptor is
present in brain arcas, including those relevaní for Ihe
rewarding properties of drogs of abuse (Gardner & Lowinson,
1991), in greater abundance Iban mosí other known receptors
for neurotransmitters (Herkenham et al., 1990).
Since the isolalion of THC, many studies have addressed
[he effects of this and other active cannabinoids in brain
fuoction (Dewey, 1986). The pharmacological profile of [he
cannabinoids includes the acute induction of analgesia,
hypothermia, immobility, and catalepsy (Abood & Martin,
1992; Martín-Calderón el al, 1998), as well as neuro-endociine
alterations, including the activation of Ihe pituitary adrenal
axis and the inhibition of the secretion of most anterior
pituitary hormones (Martín-Calderón et al., ¡998; Rodríguez
de Fonseca el al., 199 Ib, Rodrígue¿ de Fonseca, Villanúa,
Muñoz, San-Martín-Clarke, & Navarro, 1 995b). Cannabinoids
also activate monoaminergic systems in the twain, especially
reward-related systems (Garduer & Lowinson, 1991; Molina-
Holgado, Fi Molina-Holgado, E., Leret, González, & Reader,
1993: Navarro ct al., 1993a, 1993b, in press; Rodríguez de
of the Research Trends developed since 1993 at the Instituto




MEDICAL USES OF CANNABIS
ISOLATION OF PSYCHOACT¡VE CANNABINOIDS
SYNTHETIC CANNABINOIDS
DISCOVERY OF CANNABINOID RECEPTORS ~CB-l)
CLONINO OF CB-¡
ISOLATION, BIOCHEMISflY, & ROLES OF ANANDAMIDE
SYNTHESIS OF CE-I ANTAGONIST
ISOLATION & ROLES OF 2-ARA-G
DESCRIPTION OF UPTAKE SYSTEMS
3000 B.C. Traditional Asiaíic Medicine. Mechou¡am et al., ¡986
Gaoni and Mcchoulan,, ¡964
Mechoularn el al., ¡987
Devane et al., ¡988: Herkenham el al., ¡990
Malsuda el al,, ¡990
Devane el al., 2992; Fride and Mechoulan,, ¡993; Di Marzo el al., 1994
Rinaldi-Carmona et al., ¡994
Mechoularn et al., ¡995; Siella et al., ¡997
Beltramo el al., ¡997
B.
BEHAVIORAL TERATOLOGY OF CANNABINOIDS Navarro el al., 1994ab, 1995, 1996; Rubio et al,, 1995, 1998
CANNABINOIDS & OOPAMJNERGIC SYSTEMS
NEUROENDOCRINOLOGY OF CANNABINOIDS
CANNABINOIDS, STRESS, & ANXIETY
Navarro et al. ¡998; Rodriguez de Fonseca el al., 1994a and b
Martín-Calderón el al., 1998; Rodríguez de Fonseca et al., ¡995
Navarro et al., [997; Rodríguez de Fonseca el al., 1996
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Fonseca et al., 1 992b; Rodríguez de Fonseca, Martín-Calderón,
Mechoulam, & Navarro, 1 994a), and induce anxiety-like
behaviors in laboratory animais and hurnans (Dewey, Gardner
& Lowinson, 1991; Halikas, Weller, Mouse, & Hoffman,
1985; Navarro et al., 1993a; Rodríguez de Fonseca el al.,
1996). Most of these effects can be elicited after acute
administration of anandamide (Fernández-Ruiz et al., 1997;
Fride & Mechoulam, ¡993; Romero et al., 1996) although
with some exceptions (Fride e[ al., ¡995). Additionally, the
recent synthesis of the first cannabinoid receptor antagonist,
SR 141716A (Rinaldi-Carrnona et al., 1994) has contributed
to establish the existence of an endogenous cannabinoid tone,
regulating both motor activity and emotional responses
(Gueudet, Santucci, Rinaldi-Carmona, Soubrié, & Le Fur,
1995; Navarro et al., ¡997) and has provided a tool with
which to unmask dic neuro-adaptations underlying chronic
cannabis exposure (Rodríguez de Fonseca , Carrera, Navarro,
Koob, & Wciss, 1997).
The investigation of the effects of maternal exposure to
cannabinoids on brain development has been a very active
field of research in the cannabinoid field. Animal research
has revealed the existence of long-term bebavioral
consequences of maternal exposure to drugs of abuse during
gestation and lactation (Navarro,Rodríguez de Fonseca,
Hernández, Ramos, & Fernández-Ruiz, 1994a; Navarro,
Rubio, & Rodríguez de Fonseca, 1994b; Robins & MilIs,
¡993; Zuckerman, ¡991). However, knowledge of tbe real
impact of maternal exposure to cannabis on the development
and adult expression of cognitive and behavioral functions
in humans is far from being achieved. Cannabis sativa
preparations remain the most widely used illicit drugs during
pregnancy in wes[em countries (Abel, 1980; Day et al., 1994;
Fried, 1995). Cannabinoids can be transferred from the rnother
to the offspring through placental blood during gestation
(Hutchings, Martin, Gamagaris, Miller, & Fico, ¡989) and
through maternal milk during lactation (Jakubovic, Hattori,
& Mc Geer, ¡977). The presence of psychoactive cannabinoids
in the developing brain might interfere as epigenetic factors
with the rigidly ordered developmental program thaI occurs
during te oníogeny of the central nervous system, resulting
in neuro-developmental alterations (Mirmiran & Swaab, ¡987).
Early laboratory studies had sbown that maternal exposure
to either cannabis extracts or THC resulted in ¡ong-lasting
alterations in brain development and function (Abel; Brake,
l-lutchings, Morgan, Lasalle, & Mt, 1987; Dalterio & Bartke,
1979; Fernández-Ruiz, Rodríguez de Fonseca, Navarro, &
Ramos, ¡992; Hutchings, Morgan, Erake, Shi, & Lasalle,
1987; Rodríguez de Fonseca, Cebeira, Fernández-Ruiz,
Navarro, & Ramos, ¡99 la; Rodríguez de Fonseca, Cebeira,
Hernández, Ramos, & Fernández-Ruiz, 1990; Rodríguez de
Fonseca, Hernández, de Miguel, Fernández-Ruiz, & Ramos,
1992a; Walters & Carr, 1986). Subsequent studies developed
in our laboratory (Table 1, references in section E) revealed
that maternal exposure to cannabinoids resulted in behavioral
alterations which could be observed either during development
or at adult ages. Ihese alterations were associated with neuro-
chemical disturbances in nionoaminergic and neuro-pepúde
systems (Bonnin et al., 1994; Molina-Holgado et al., 1993;
Rubio et al., 1995).
An unexplored aspect of the behavioral teratology of
abused drugs is teir possible role as a vulnerability factor for
drug-seeking behavior in the adult. Several studies have shown
that maternal exposure to opiates (Gagin, Kook, Cohen, &
Savil, 1997) or to psychostirnulants (Keller, Lefevre, Raucci,
Caríson, & Glick, ¡996) resulted in a sensitization to the
reinforcing effects of these compounds in the adult offspring,
suggesting te establishment of a vulnerability as a result of
that early exposure. The neurobiological mediators for the
establishment of such vulnerability remains to be de[ermined.
However, tbe pioneer work of McEwen and colleagues (1987,
and references therein) has established that underlying such
altera[ions may be the drug exposure-induced effects on
maternal steroid-hormone secretions or the intrinsic activity
of such drugs, which ací as steroid hormone-like substances.
Most dmgs of abuse are potent activators of te hypothalamo-
pituitary-adrena¡ axis (HPA), aud it has been proposed that
maternal stress induced by Ihese drugs migbt underlie [he
observed behavioral sensitization (Molina, Wagner, & Spear,
1994; Rubio et al., 1995). The effects of such epigenetic
intIuences in brain reward systems bave been studied by the
exíensive research of Piazza’s group ( Piazza, Deminiere, Le
Moal, & Simon, 1989; Piazza, Deroche, Derniniére, Maccari,
Le Moal, & Simon, 1993; Piazza & Le Moal, 1996). These
authors have suggested that both prenatal stress and prenatal
drug exposure seem to play an importaní role in te individual
predisposition [o psychostimulant self-administration in rodents,
by the induction of long-term changes in the activity of
mesocorticolimbic- projecting dopamine neurons containing
glucocorticoid receptors (Harfstrand et al., 1986), and HPA
activity in te adu¡t offspring (Callaghan et al, 1994; Deminiére
et al., 1992; Macean et al., 1991). In this regard, tere is little
information about te possible long-term vulnerability-inducing
effects of maternal exposure to marijuana or its psychoactive
compounds. Natural cannabinoids, sucb as THC are potent
activators of the HPA axis by means of its interaction with
hypo[halamic brain cannabinoid receptors (Rodríguez de
Fonseca et al., 1991b,1995b). Perinatal exposure to
cannabinoids might ten result iii increased maternal circulating
¡evels of corticosterone and could iníerfere with the
development of te HPA axis in te fetuses. ‘[he fact diaL
brain cannabinoid recep[ors are present in early stages of
development (Rodríguez de Fonseca, Ramos, Bonnin, &
Fernández-Ruiz, ¡993) adds another important biological
substrate to the actions of maternally-delivered cannabinoids
on brain development.
The present study was designed to further analyze the
effects of maternal exposure to THC in the reinforcing
properties of morphine in the adult offspring. Previous studies
have shown that endogenous opioid systems (peptides and
teir receptors) can be altered after maternal exposure either
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to stress (Insel, Kinsley, Mann, & Rridges, 1990; Keshet &
Weinstock, 1995) or to perinatal cannabinoid treatments
(Kumar et al., ¡990). Because of the growing evidence that
thc functional status of tbe HPA-axis rnight be relevant for
opiate-seeking behavior in the rat (Saham & Stewart, 1995),
sensitivity to the reinforcing properties of a moderale dose
of morphine (350 pglkg, which induces place-condi[ioning
in only 50% of the control anirnals) was studied in adult
offspring born of mothers exposed during gestation and
lactation [o several doses of TI-IC thaI were closely relatad
to human consump[ion. ‘[he functional status of tbe HEA axis
was evaluated by rneasuring plasma levels of ACTI-l and
corticosterone in basal condi[ions, and after the adap[ive
challenge of conditioned place-preference (CPP) testing.
Another stress-re¡ated hormone, prolactin (PRL), was also
controlled. Since increased sensitivity lo [be reinforcing
effects of abused drugs bas been associated with changes in
the pattcrn of locomotor and exploratory activity (Piazza ct
al.. 1989), we also evaluated the behavioral response [o novel
aud familiar environments, using a battery of behavioral tests.
Lastly, in order to further evaluate the estab¡isbment of long-
lasting functional alterations as a result oF maternal
cannabinoid exposure, we studied ihe effects of maícrnal
exposure to the highly potent cannabinoid, (-)- ¡ ¡ -hydroxy-
d-tetrahydrocannabinol-dimethylhepíyl (HU-210), on Ihe




Female virgin rats of the Wistar strain (> 8 weeks oíd;
2(E-250 g) were housed in a room with conn’olled photopexiod
(¡igbts on: 08:00-20:00) and temperature (23 ± lcr). Thcy
had free access to s[andard food (Panlab, Barcelona) and
water Daily vaginal smears were taken between 10:00-12:00
b, and only those anirnals exhibiting Ibree or more consistent
4-day cycles were used in this study. Females in the proestrus
phase were allowed to stay with a male for ma[ing, and a
new vaginal smear was taken on tbe next day. Those animals
showing (he presence of sperm celis were accepted as
probably pregnaní and used for jt tetrahydrocannabinol or
HU-2l0 exposure studies. ‘[be day on which sperm plugs
were found was designated the firsí day of gestation. After
weaning the offspring, they were separated and housed, 4-5
animals of the same sex and treatment per cage. Thirty litters
were used for the behavioral studies, distributed as follows:
8 vehicle, 4 THC ¡ mg/kg, 4 THC 5 mg/kg. 3 THC 20 mg/kg,
4 HU-210 1 pglkg, 4 HU-210 5 pglkg, and 3 HU-2¡O 25
¡iglkg. Por both CPP and defensive-withdrawal studies, 2-3
male offspring aral 2-3 female offspring por litter were chosen
randomly at adulí age (>70 days). Female rats were studied
in the estrous pbase of the cycle.
Cannulae implantation. For [he ti me course of the
endocrine ac[ions of HU-210, a group of six animals por
trcalrnent was implanted under Equithesin anesthesia with
indwelling atrial cannulae, inserted via the rigbt external
jugular vein. Cannulae were filled witb hepariniLed salme
(lO U/mi) lo maintain patency. AnimaN were allowed al
leasí 48 hours ¡br rccovery, prior to experimental procedures.
AII the procedures were carried out according to the
Furopean Cnmmunities Council directive of 24 November,
¡986, (86/6<19/EEC) rcgulating animal research.
Experiments
In the t’irst experiment, we studied the performance on
the elevated plus-maze of maje and female offspring who had
undergone the diffcrent perinatal [reatments wi[h TI-IC during
pos[natal development. ‘[he animals were rcpeatcdly exposed
to the maze al 2<), 30, 40, and 70 days of pos[natal life.
[u lEe seceud experirnení, adulí animais of both sexos
(>70 days). born of mothers exposed lo Ihe different
experimental trea[ments. were studicd in Ihe defensivo-
withdrawa¡ test under novelty conditions (Rodríguez de
Fonseca et al., 1996). Ono wcck after the testing procedure,
íhey were divided into two groups. Rats of the first group
werc left undisturbod for íwo addi[iona¡ wcoks. ‘[he animals
were killed aftor babituating Ihein tu Iho bandling procedure.
aud plasma samplos were obíained (basal group). The second
group was used to síudy tho effects of perinatal exposure [o
THC un the reinforcing properties of a moderate dose of
morphine (350 pg/kg, Rubio et al. ¡995), using the CPP
paradigm. Locomotor aclivity was measured during
conditiuning sessions. Iheso animais were killed afíer Ibe
end of the 45-minute tosting sessiun of the CPP tost, and
plasma samplos wore collected (placo-proference group).
In the third experiment. animals expused tu (-)-l 1-
hydroxy-AtTetrahydrocannabinol-dimethylheptyl (HU-2 10)
wero usod for evaluating the time-course of the adrenal
response lo an acule cannahinoid challenge. Adulí animals
from Ihe differen[ gruups (u = 6; > 70 days) bearing
indwelling atrial cannulac wore injocted with I-IU-210 (20
pglkg, iv), aud plasma samples were obtained from Ihe
jugulce vein -20,0.30,60, aud 120 minutes befure aud afta
Ihe injection of [he cannabinoid agonisí.
Drugs ¿vid Treatments
Fermata! cannabinoid exposure. A9-tetrahydrocannabinol
(THC) of greater than 95% purity was provided in an ethanol
solution by dic National Instituto on Dmg Abuse (Projecí 488&
OB). (-)-I 1 ~hydroxy~fl&tetrahydrocannabinol~dimethylbepty¡
(HU-210)HU-210 was a gil by Dr. Raphael Mechou¡am, from
‘[be Hebrew University at Jemsalem. It was dissu¡ved in 95%
elbanol al a concenuation of lO mg/kg. lmmediately before
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use, te etanol was evaporared and te residuo was omulsifiod
using sosame oil as the vohiclo. Pregnaní femalos received a
daily single oral duse of THC (1, Sur 20 mg/kg budywoight,
given betwoon 10:00 and ¡2:00 am.), HU-210 (1,5 ur 25
vg/kg) ur vehicle in a volurno uf 0.1 ml. ‘[he treatment síarted
in the fifth day of gestation and was maintained until the 24t11
day afíer birth, Iho day un which pups were weanod. The dosos
of THC chosen wero an exírapolatiun frum curron[ ostimales
of moderato tu heavy expusuro tu Ihis cornpuund in humans,
and were corroctod. considering Iho differencos in route of
administration and budy surthco area (Rusenkrantz. Spraguc,
Floischman, & Braudo, ¡975). Wc have proviuusly ubserved
thaI this dusago rosulted in plasma THC lovols wiihin tbo rango
of thuso reponed causing behavioral and physiulugical effec[s
in animal modols (Navarro et al., 1993b; Rodríguez de Fonseca
et al., 1991b). I-IU-210 doses wero soloctod un tho basis of its
oquipotency with ‘[HC (Rodríguez de Fonseca ot al. 1995b,
1996). Tu assoss tho pussib¡c tuxic effects of the trealmoní
proviously reponed (Brake. Hutchings, Murgan, Lasalle, &
Shi, 1987; Huíchings cí al., >987), sovoral gosialional and
lactational paramo[ers wero cuntrolled, as describodelsewbore
(Navarro el al., 1994b). Figuro 1 depicís the lack uf consistent
effects of matemal expusure tu THC on fund- and water-intake
during gestation and lactation. A similar profile was observod
aher HU-210 exposuro.
Morphine treatment. Murphino hydrochloride was usod
for the CPP studios. It was supplied by Centro Nacional do
Estupefacientes y Psicótropos. proparod daily using isotonic
salino as vohicle, and injocled intrapcri[oneally al [he dosos
described in Ihe Experimonís Soction, in a volume of 0.3
ml. Nono of the morphine doses tosted induced pbysical
dependence. as ovalualed using naloxone (1 mg/kg) afler
Ihe 3-day cunditioning sessions (Rodríguez do Fonseca el
al., 1995a).
Acute HU-210 exposure. HU-210-induced a¡tera[iuns in
Ihe secrotion of corticuslerone and prolaclin wore studied
in animals boaring indwolling atrial cannulae. HU-210 was
preparod in saline/prupylene-glycol/Tween 80 vehiclo (90:5:5
y/y), and injected intravenously al a duso of 20 ¡.iglkg in a
vulume uf ¡00 pl.
Behavioral Testing
Elevated plus-mare. The performance of Ihe uffspring
in the elovaled plus-mazo was repeatodly evaluatod at
postnatal days 20,30,40, and 70, fullowing previuusly
described rnotbuds (Rubio el al. 1995). The rosulís woro
exprossed as 1) tho absoluto time spont in Ibe exposed arms
uf Ihe mazo, and 2) [he number of arm entries. AII ibo
bohavioral studies look place during the murning limo of
tho light cycle (09:30 - 13:00 br)
Defensive withdrawal. Defensive-withdrawal tesí was
cunducted as previously describod (Rodríguez de Fonseca eí
al., ¡996). Tho apparatus consis[ed uf an opaque opon field
(¡00 x lOO x 40cm), the fluor of which was marked with
20 x 20 cm squaros. ‘[he field containod a cylindrical
polyethylono chamber, measuring 17cm deep and 10cm in
diameten ‘[he chamber was upen al uno end arel si[uated
alongside Iho wall running lengthwiso and 20 cm away frum
a comer of Iho opon tield. me upen tiold was illuminated
íísing a 500 W halogon coiling lighm. which was rogulalod lo
yield 350 lux al Ihe centor of iho upen fiold. Tosling was
cunductod only under novelty conditiuns. as descrihed in Ihe
Experimcnts Section. ‘[he rats wore placed inside iho chamber.
in Ibo opon field, aud the fullowing bohaviors wcre scorod
by trainod uhsorvers, who were blind tu experimental
cundi[iuns: ¡atency in leaving Iho chamber (emergence
laíency), definod as placemení of alí fuur paws in Ihe upen
fleld; thc tulal time spenl in Ihe chambor; tho mean lime spent
in te chamber (i.e.. the tolal time spont in ihe chamber
divided hy the total numbor uf entrios); motor activity, defined
as tho total number of ¡mes un the fluor of Ihe open ficíd
crussed uuísido te chambor (crussings>, and iho numher uf
rearirigs performed culsido the chamber. ‘[he Cosí length was
¡5 mm. Aher testing each animal, Ihe apparalus was cleaned
witb a woak acid solulion (1%. acotic acid) tu prevent olfacloiy
cues frum affecting Iho behavior uf subsequenlly tesíed rats.
Conditioning. Morphino-inducod placo preforence (CPP)
studies wero performed as proviuusly doscribed (Rodríguez
do Fonseca ci al., 1995a), using a throe-arm apparatus similar
tu Ihal descrihed by Hand, Slinus, & Le Moal (¡989). ‘[he
apparatus cunsistod uf throo intercunnocted rectangular boxes.
measunng 40 x 35 x 35 cm, situatod at 12(1’ anglos from each
uther. In ihe middle, there was a triangular area wiíh a smooth
glass Iluor, Irum which any uf the threo cumpartments were
accessible. Each cumpartment was equipped with a differenl
set of sensury síimuli: compartmení A was equipped wilh a
sand tluor. plain walls, and a small containor wiíh a drup uf
¡0% acetic acid. Comparímení E cuntainod a romuvable sufí
plaslic fluor, walls painted wiíh white dut circlos (7.5 cm),
and a small cuntainer with a drup of aniso oxtract. Finally,
compartmen[ C had a cork tioui; altornating whito strips (5
clii wide) painted un ¡he walls. and no odur (a container with
distillod walor). ‘[he apparatus was placed in a dimly
illuminated (11<) Lux) isolated room. Each cumpartmenl was
equipped with eighl photucolls which allowed us [u monitor
tho pusition of Ihe animal, and lo autumatically registor the
timo spenl in cacb compartmenl. Afler lesling each animal,
the floors were changed ai~d washod lo avuid odur cues. Each
CPP experimení cunsistod of a 5-day sehodule, with íhree
phases: preconditioning, conditiuning and lesting. Animals
exhibiting strong unconditiuned avorsions (< ¡0% of tho
sessiun) or preferencos (> 60% uf Ihe session) for any
compartmonl in the 45-minuto precondiíioning session were
discarded for the conditioning procedures. ‘[huso lwo
cumpartmenls tu whicb Ihe animals exhibited te musí similar
preference-time wero randumly assigned for ihe cunditioning
procedure. This cunsisted uf a 3-day sehedulo of double
cundilioning sessions. The first day invulved a momning session
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(9:00 - 13:00) in wbich animals received a single duse uf
morphine (a fulí duso-rospunse (experimení 1 ( or 350 g/kg
ip, in THC-exposod animals) and were immediaíely placed
in ono of Ihe cumpartrnents. During Ihis 30-mm cunditioning
session, tho animals were not a¡lowed tu explore Ihe other
compartments uf te apparatus. In [he evening session (16:00
- 19:00) tho animals received a single intraperitunoal injeclion
uf salino solution, and were placed for 30 mm in the other
cornpartment choson for conditioning. On Iho second day of
cunditioning, Iho rats received the salino injoctions in [he
morning sessiun and [he drug administration in Iho ovening
session. On Ihe third day uf cunditiuning, [be same sohodulo
was usod as un Ihe first une. On the basis uf preliminary
gludios in unir laboratury, we chuse Ihis schedute [o avoid
circadian variability (morning/evening). Aftor three days uf
conditiuning, [he animals were again allowed tu freely exploro
Ihe lhree compartmonts, as in [he precunditioning phase
(testing session). The absoluto time spent in each cumpartment
was automaíically registerod and used fur Iho evaluatiun of
[he CPP.
Locomotor activity. During the different conditiuning
sossions, [he pusitiun of Ihe animal in the cumpartment was
autumatically registered by means of the photocells systom
described aboye, and Ibe tutal numbor of beam interruptions
was used for tho analysis of locomotor ac[ivity (Rodríguez
de Fonseca et al. 1 995a).
Sampling and Hormonal Deíerminations
Throo hundred microliters of bluod wore withdrawn at
-20,0, 30, 60, and 120 minutes boforo and after Ihe injection
uf HU-210 from [hejugular vein witb a heparinizod syringe.
Sixly minutes after ub[aining Iho lasí samplo, tho animals
were saerificed by rapid decapitation using a guillotine.
Animais were previously farniliarized with this handling
proceduro. Trunk bluod was collected in tubos containing
400 ¡tI of 6% EDTA, and centrifuged at 2500 x g at 40C.
Plasma was stored, frozon al -200C, until assayed fur
hormonal determinatiuns. Plasma curticosterono levels were
measured by a radioimmunu-assay system (RIA), using a
speciflc antibody from Bio Clin (Cardiff, Walos). This RíA-
systern yiolds basal values of corticosterone of ¶75 ±25
ng/ml in undisturbod adult malo animals, and 500 ±70 ng/ml
in stressod animals (Rodríguez de Fonseca et al., 1996). ‘[he
variability uf the method was ¡5.3%, and [he detection limit
was 62 pg/ml. Plasma PRL levels wero moasured, as
previously described (Rodríguez de Fonseca et al., 1995b),
by a spocific doub¡e-antibudy RIA-system, using ma[eria¡s
kindly provided by [he Natiunal Hormune and Pituitary
Program (NIH, Belbesda, MD, USA). Values aro expressed
in ng/ml of roference preparalion rPRL-RP3. Tho intra-assay
cuefficient of variation was 3.3% and Ihe sensitivity was
0.025 ng/ml. AlI sainplos wero measured in the same assay
tu avoid interassay variations.
Statistieal Analyses
Twu levels uf analysis were performed in Iho presení
study. Dala of individual animals wero assessed by
mul[ifaclorial analysis uf variance, as required. Fullowing a
signifocant E value, post hoc analyses (Newman-Kouls) were
performed fur assessing specifoc gruup comparisuns. Lilter
analysos wore perfurmod following 1-lolsun ciad Pearce (¡992)
suggestions, in order tu assess [he presence uf lilter effects.
‘[o this end, ANOVAs were perfurmed using the mean litíer
value ubservod as Ihe unit lur analysis. AII calculaíions were
performed using the BMDP statistical package.
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figure 1. Lack of consisteor effocís of maternal expusure tu THC
(0, 1, 5 or 20 mg/kg} un ibud- and water-intake during gestation
and laclalion. Ordinales are means of the daily inlake of oither
standard food pellets nr tap water. (*) p < 0.05, Newman- Keuls,
















CANNABIS AND ADDICTION VULNERABILITY 45
Efjécts of Perinatal Exposure to THC on Several
Gesitational and Lactational Parameters
In order lo assoss the possible loxie and nutritional effects
uf ‘[HG administratiun, repurted elsewhere (Brake et al.,
1987; Hutchings et al., 1987), we recorded several parametors
throughuut Ihe gosíation and lactatiun (seo Figure 1), as
previously described (Navarro et al., 1994b). Our results
shuwed that treatment with ‘[HC 20 mg/kg reduced maternal
food-intake during the first day of treaímenr (simple offect





























= 8.7, p < .003, disappearing thereafter. Moreover, overalí
ANOVA analysis did nol reveal differencos in matemal fuod-
intake throughouit the entire gestation, 1(3, 12) = 1.2, p =
.35 (nonsignificaní). Mothers exposed tu THC 1 mg/kg drank
more wator during gestation, F(3, 12) = 4.6, p < .02,
althuugh this effect disappoarod during the lactational poriod.
Perinatal ‘[HG exposure did nul result in differences either
in maternal weigbt-gain, or in Ihe size and weight of tho
lilíers (data not shuwn). Weigbt gain of the offspring,
measurod un postnatal days lO, 15, 20, 30, and 40 was equal




































































Figure 2. Developmental porformanco in Ihe elevated plus-mazo of maje and fomale uffspring perinatally exposod lo THC (0, 1,5 or
20 mg/kg). Uppor panel, Urne spent in Iho oxposed arms; lower panels, total arm entiles, Values are means ±SFM. of 8-12 doterminations
por group. (*) p =<1.05, Newman- Keuls, versus vehicle-trealed animaN.
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Effects of Maternal Exposure tu THC un Behaviural
Pe4bnnance iv the EIeí’ated Plus-Muzí’
The analysis uf thc perfurtuance in Ihe elevated plus-
maze rovoaled a doveloprnenlal cffrct boíh in the timo spent
lii the exposod arms ant> in dio nuniher uf arm entiles. 1<3.
303) = ¡2.7, p < .0001, and F(3. 3<13) = 22.2. ,‘, < .0001.
respectively. with a markedly difíerení response in Ihe adulí
age (postnatal dey 70). Both otfects appoarcd as a rcsult uf
maternal oxposuro lo THC: main effect of maternal trcatrnent,
1(9, 303) = ¡.9, p < .05; and [‘(9, 3031 = 3.6, p < <105.
frr time spení uuí and arm erarios rospecíi vely. flowevor,
the naluro uf Iho alterations in expluratury and locomotor
behaviurs soemod tu be differont. Thus, a clear sex x
trealment x pustnatal—day inícíaclion appeared in Ihe analysi s


































3,9, ,o < .01: malo ollspring uf muthers expused tu cilber
TiIC 1 ur 5 mg/kg oxhibited bigher expluralury bobavions.
whereas Ihuse exposod tu 11 IC 20 mg/kg exhibited a constaní
tondoncy lo avoid ihe expluration of tho expused arms uf
[he mase. Femalo offspring also oxhihited changos in the
panero u> expiuretion u! Ihe upen anos un pusínatal dcv 70.
altbuugh the changos were 1101 dose-dependont, appearing al
‘[lIC ¡ and 20 mg/kg. híít no? al 5 mg/kg. Regarding
locomotor activity in tbe mase, malo offspring nf muthers
exposed lo ‘[HG 20 mg/kg exhibitod a significaní decreaso
in thc number of arm oníries íhruughout devoluptuení. Adull
uffspring expused tu ‘[lIC 1 mg/kg oxhibitod cm upposite
pattern un pusínalal day 70. wi íb a high n umbor of arm
cotries. Females displaved sume changos tliruughuut
devoluprnent, hui thoy vero nuí consistení. and were not








































Figure 3, Bohavioral reactivity tu nuvolry, as measured fo dio defonsive-withdrawal 1051, in malo and female anin,als hora of muthors
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Effects of Exposure tu THC un the Peiformance of
Adult Offspring iv the Defensive-Withdrawal Test
under Novelíy Cunditions
‘[he paííern uf behaviur displayod in the defensivo
withdrawal test was clearly sex-dimorphic, as reflocted in
the sevoral paramoíers scured: female animals emerged
befure males, [‘(1, 81) = 23.9, p < .000?. they remained
less time inside ihe tubo. [‘(1. SI) = 29.7, p < .0001, and
they exhibited higher motur-activity seores Iban males for

















[‘(1,813=39.7, p <.0001. Maternal exposure tu THC ¡ ur
5 mg/kg. buí nul tu 20 mg/kg resulted in a decreased
emergence laíoncy in malo uffspring: sex x treatment
interaclion, [‘(3,81) = 3.01, p <.04. Malo offspring ofíhe
‘[HC 1 mg/kg group remainod less time inside ¡he tubo, [‘(1,
25) 8.75, p <.01, and íhey also exhibited a lower mean
time spent in dio small chamber when comparod tu control
animals. [‘(1, 25) = 5.5?, p < .03 (dala not shown). A
significaní sez x treatmenl interaction was also observed in
buth the number of crossings, [‘(3, 81) = 4.72. p < .005,
and rearings, [‘(3, Sí) = 4.2, p < .01. scured during Iho tesí.
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LOCOMOTOR ACTIVITV AFTER MORPIjINE
Figure 4. Locomotor activiíy uf malo and fomales aniínals perinatally exposed tu THC (0, 1.5 ur 20 mg/kg) in Ihe placo-cunditioning
mase measured in: (A) unírcated habituated animals: (B) during the tirsí conditiuning session with morphine; and (C) during Ihe lasí
conditioning sossion with murphine. Ordinates are the number of beam breaks registered for 45 mm ± SEM of 8-12 determinaíions por
group. (*3 p < 005. Newman-Keuls, versus vehicle-treared anin,als.
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EJfrcts of Maternal Exposure to THC on
Spontaneous and Morphine-Assuciated Locomutur
Activitv
Maternal exposure tu ‘[HG did not result itt alterations
in sponlaneous unconditioned locomution exhibited by adult
animals, independently uf Ihe sex variable. However, the
responso lo morphine ubsorved during conditioning sessions
was sexualíy dimurphic, F(¡, 53) 13 1.2, p< .005, and
was affected by porinalal expusuro tu THC, [‘(15, 265) =
2.4!, p < .05. Animals of Iho vohicle group did nut show
altered locomotion after murpbine 350gg/kg troatment during
conditioning sessiuns <seo Figure 4B and 4C). Huwevor,
malo animais bom from mothers oxpused tu ‘[HG 5 or 20
mg/kg exhibited a differential responso tu ñrst morphine
when compared wilh ‘[HG ¡ mg/kg gruup, [‘(3, 53) = 3.7,
p < .05. This differeníial responso cuuld he slill ubsorved
in the íliird conditioning sesgion, un which a sensirized
locomotor response tu murphine appoared in animais uf Ihe
THC 1 mg/kg group, [‘(1, 12)=4.l, p= .05.
Effects of Maternal Expusure tu TI-fC en Morphine
Place-Prefrrence in Adult Offspring
Maternal expusure tu low dusos uf THC resulted in
enhancod sensitivity lo dio reinforcing proporries uf
murphine 350 pg/kg displayed by the adult offspring, as
meastíred in tbe place preforence paradigni, [‘(3, ¡24) =
4.4, p < .005.’[he effect was sexually dimorphic, [‘(1, 124)
= 11.1, p < .00]. Malo offspring of Ihe THC ¡ and 5
mg/kg duso group increased their preferonce for Ihe
morphine-paired cumpartment with respect tu the salino-
paired cumparímení, [‘(3, 60) 3.3, p < .03. Only fomale
uffspring of Ihe ‘[HG ¡ mg/kg gruup incroased [hoir
proferonce for Ibo morphine-paired compartmont wilh
respoct tu the saline-pairod cumparímení: simple offect of
maternal oxposuro lo ‘[HG ¡ mg/kg. a, 64) 5.7, p
.03. Neithor cuntrol-offspring flor [huso buin of mothers
expused tu ‘[tIC 20 mg/kg exhihited a decir proforonco for
11w murphine-paired cumparímoní when cumpared lo [he
saline-pairod une.
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Figure 5. Murphine (350 gg/kg)-induced place conditioning expressed as te percontage of chango ovor proconditioning lime values.
(*) p < 0.05, Newman-Kouls, morphine-paired vorsus saline-paired cumpartment.
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Figure 6. (A). Changes in corticostorune levels (exposed/basal ratio x lOO) assuciatod with the oxposure tu Ihe condiliuning mazo in
adulí malo and femalo animals born uf moíhers exposed lo THC during gesíation and lactation. (B) Changos in plasma-prolactin leveis
(exposed/basal ratio x lOO) associated with Ihe oxposuro lo Iho condilioning mazo in the same animals. (C) Pusilivo correlation botween
plasma-corticostorone loveis and proforonco fui murphino-paired eumpartment in males uf Ihe THC 1 mg/kg doso gruup, buí nol in
vohiclo-group animals (D). (*) p c 0.05, Newman- Kouls, versas vohicle- Ireated animals.
Effects of Maternal Exposure to THC on ¡‘¿asma
Hormonal Leveis aJter Morphine Place-Preference
Ecisal corticosterone levels (data not shown) wore sex-
dimorphic, F(l, 83) = ¡2.03, p < .001, and they wore
clearly affoctod by maternal exposuro to THC: sex x
trecitment interaction, [‘(1, 83) = 7.66, p < .01. Maternal
oxposure tu ‘[HG resulted in high basal corticosterono lovols
in fernalo offspring and reduced basal levels uf Ihis steroid
in malo offspring of tho ‘[HG ¡ mg/kg group. Exposure tu
te place- preference tost incroased [he leveis of this adrenal
steroid: tesí effect, F(l, 141) = ¡0.2, p < .005. ‘[he ratio,
corticosterone levels (CPP groups)/average basal
corticusterono levels, displayed marked sexual dimorphism,
[‘(1, 62) = 16.7, p < .0001, showing a clear offect of
maternal troatmorot, [‘(3, 62) = 6.8, p < .0005, and ci mcirked
treatment interaction, [‘(3, 62) = 12.85, p < .0001,
which revealed that malo offspring of muthors exposed tu
THC-l mg/kg displayed a higher increase in corticosterone
levois as a result of the exposuro tu the CPP test (Figure 6).
‘[his activalory offect cissociated twith CPP testing was not
observod in males from the low THC-expusure groups when
plasma prolactin was analyzed. Moreover, it appeared in alí
females, indepondently of maternal TI-IC exposure, and in
males from Ihe 20 rng/kg-dose group. Regression analysis
revealed thaI the chango of preference for Ihe morphine-
paired compartment correlates positivoly with plasma
corticosterone levels in males of the ‘[HG 1 mgAg-groups,
[‘(1, 8) 6.75, p <.04, r = 0.49. ‘[his positivo correlation
was not observod in Ihe remaining experimental groups.
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Table 2
Liver Analysis of Me Effecrs of Perinatal Expusure




TI-IC ¡ (mc/kg) THG 5 (mc/kg) THC 20 (me/kg)
Emergenee latency
Males 438,4±¡52.8 87.9±28.3(*) ¡52.6±36.5 (~) 298.7 ±¡84.9
Fomales 25,1 ±8.2 26,9±¡3.2 ¡5.3±5.1 14.6±2.9
Chango of preference
Mates 284 ±177.5 715.9±246.2(*3 386 ±50.8 36.8 ±84.4
Fomales -53.5 ±73.6 ¡92.5±¡34.7 79.8 ±22.9 -159 ±79.1
Basal ACTH (pg/ml)
Malos 126.1 ±¡0 296 ±73.7 (~) ¡30.4±¡7.6 ¡14.9±42.4
Fon,a¡es 109.9 ±¡4.2 52.4±31.6 169.7±64.4 ¡01.1 ±4.9
ACTH post CPP (pg/ml)
Males 464.2 ±34.3(#) 248.6±23.6 (*) 320.1 ±46.5(#) 292.3 ±64.2(#)
Females 367.7 ±93.3(#) 220.9 ±26.2 288.3 ±73 218.0±38.7(#)
Basal Corlicosterono (ng/mí)
Males 221.5 ±63 ¡23.4 ±¡O(~) ¡74.4 ±13.3 271.9±¡LS
Females 339.0 ±73.3 646.1 ±102.9 (*) 421.9 ±111.8 394.2±90.5
Curricosterone pusí GPP (ng/mí)
Males 408.5±65.2 525.3±77.9(#) 384.0 ±31.8 397.0 ±84.1
Femalos 413,7±¡00.1 451.5 ±122.7 479.0 ±¡¡0.5 529.5 ±37.2
* p < 0.05, Nowman Keuls versus vohicle-trecited gruup. # p < 0.05, Newman Keu¡s versos basal group uf Ihe gamo treatment.
Litter Analysis of the Effects
So TJJC
of Perinatal Exposure
Lilter analysis showed thaI perinalal exposure tu ‘[HG ¡
or 5 mg/kg resulted in a significant decreaso in Ibe emorgence
latency and in a tendency tu oxhibil a decroase in tho total
time spont in the compartment of te defensive-withdrawal
tosí, [‘(3,22) = 3.91, p <.02, and [‘(3,22) = 2.52, p <.08,
respectively. ‘[hero wcis marked sexual dimorphism in the
porformance of this íest, as described aboye, cind perinatal
THC exposuro failed tu induce alterations in female offspring.
‘[he offects of perinatal lreatmont with ‘[HG 1 mg/kg un
murphine-induced chango of place proference were presení
when Ihe mean litter value was considered as Ihe unil for
analysis, [‘(3,19) = 3.8, p < .02 (seo Table 2). Tbese offects
woro sexuaiíy dimorphic, [‘(3,19) = 8.7, p <.008, and were
signiticcirsí in males exposed tu ‘[HG ¡ mg/kg. ACTH analysis
reveciled Ihe presence uf increasod plasma-ACTH levois as
aresultofthoCPPtesting, [‘(1,44) = 35.7, p< .0001. ‘[hero
was a significaní tosí x treatment interaction, [‘(3, 44)= 5.4,
p < .004, reveciling a disrupting effect of maternal exposure
tu ‘[HG ¡ mg/kg un dio pattern of AGTI-I ¡evels displayed
by both te basal and place-proferenco groups. Lilter analysis
confirmed Ihe sex-dimorphic effecls of maternal ‘[HG
expusure un basal corticosterone lovels: sex x trealmoní
interaction, [‘(3, 22) = 4.3, p < .02; and [he different response
tu tbe CPP tesí, [‘(3, 44) = 3.8, p e .02, in males and females
as a resulí of dio exposure tu ‘[HG.
50
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EFFECT OF MATERNAL EXPOSURE TO HU-210
QN TME QLUCOCORTICOIO RESPONSE TO
ACUTE CANNABINOID TREATMENT









EFFECT OF MATERNAL EXPOSURE TO MU-210
QN TI-lE PROLACTIN RESPONSE TO ACUTE
CANNABINOID TPEATMENT
*
MOTHFR I~u-2’0 TRFATMFNT (.,nAc,1
TIME POST-INJECTION (mm.>
Figure 7 Maternal exposure lo Iho cannabinuid receptor agonisí 1-IU-210 results in alloralloas in Ihe response of both Ihe pituitary-
adrenal axis (A), and prolactin socretion (B), tu an acute challengo wilh HU-2¡0 in Iho adulí offspring. (~) p < 0.05, Nowman-Keuls,
versus f<rst fracíjon. Standard orrurs of Ihe mean woro umitíed tu impruve the clarily of the graphs.
Effects of Maternal Exposure tu HU-210 un HPA
Sensitivity tu an acute Cannabinoid Challenge
Maternal exposure tu [he highly poíent cannabinoid
receptor agonisí HU-210 resulted in a permanently altered
sensitivity of the HPA axis tu the activating offects uf
cannabinoids: doso effect, F(3, 16) = 3.7, p c .05. Maternal
oxposure tu HU-210 resulted in lower mean basal
corticosterone levels (seo Figure 7A). Afíer acute injection
uf HU-210, the animals bom from mothers of Ibe 1 pg/kg-
gruup exhibited a potentiated and long-lasting corticosterone
response, with maximal increases up tu 500% uver mean
basal levels: time effect F(5, 80) = 6,1 p <.0001. This effect
was nol observed in animals from Ihe 25 ig/kg-dose group,
which shuwed a moro subdued response of shorter duratiun:
time effect, F(5, 80) = 1.2, p = .14 (nonsignificant). Plasma-
prolactin response tu HIJ-210 in control animals was biphasic,
with a short activating responso ubsorved 30 mm after Ihe
injection and a subsequent Iong-lasting inhibition, F(5, SO)
= ¡5.07 p < .0001 (seo Figure 7B). Maternal exposure tu
HU-210 only affected Ihe stimulatory phase of tho response
tu HU-2 lO, again io the lower-dose group: absence of simple
effect of maternal treatment with HU-210, 1 .sg/kg, un 30-
mm fraction. F(5, SO) = 1.3, p = .25 (nonsignificant).
Hu-210 INJECTION
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Discussion
The prosení study shows that maternal oxposuro tu Iho
psychoactive constituont uf cannabis THC results in a clustor
of behavioral and endocrino altorations in the adulí offspring
that can be rovoaled aflor chaiJonges with drugs (upiales,
cannabinoids) or envirunmontal modificaíions. ‘[bus, maternal
exposure tu ‘[HG increasod Ihe sensitivity tu Iho roinforcing
prupertios of a moderato duse uf murphino in dio adult
uffspring, as moasured in the CPP paradigm. ‘[bis sensitivity
was greator in animals oxposed tu low doses uf Ibis
cannabinuid (1 and 5 mg/kg), and was found tu be sexually
dimurphic. Place-conditiuning inducod by morphino 350
pg/kg iii malo uffspring perinatally exposed tu ‘ERG ¡ mg/kg
was similar tu that obtained in control animals using doses
3-6 times greater (Rodríguez do Fonseca et al., 1995a; Rubio,
Rodríguez de Fonseca, Martín-Calderón, del Arco,
Bartolomé, Villanda, & Navarro, in press). A recont repurt
indicates that this increased sensitivity is extensivo tu oporant
responses for opiates, using a model of morphine self-
adminisíration (Martin eí al., 1996).The animals oxpusod
perinatally tu ‘ERG cilso exhibited sexually dimorphic changos
in [he behavioral reactivity lo novel envirunments (seo Figure
3 fur Ihe defonsivo-wiíhdrawal study) and in Iho oxploraíory
behaviors of a familiar onvironment wiíh aversive prupertios
(seo Figure 2 fur Ihe plus-mazo study). The endocrino
altoratiuns observod included sexually dimorphic alterations
un Iho reactivity of Ibe hypothalamu- piíuitary-adrenal axis
lo dio adaptive challenge of dio CPP testing. Malo offspring
born of mothors oxposed tu THC (1 urS mg/kg) displayed
normal tu luw basal lovels of corticusteruno, and an enhancod
adrenal response tu the CPP challenge. Huwover, female
offspring perinatcilly exposed tu ‘[HG (1 ur 5 mg/kg)
• displayod the opposite pattem: permanontly elevated plasma
levols of corticosterone and a blunted adrenal responso tu
tbe HPA-activating effects of dio CPP íost. Lastly, males
bum of mothers expusod lo dio polent cannabinoid HU-210
exhibited a doso-relatod altored HPA response tu cm acute
cannabinoid challengo: animals bom frum mothors exposed
tu [he low dose of the cannabinoid (1 ¡ig\kg) exhibited a
sensitizod and long-lasting response tu acute HU-210
exposure, whereas Ihoso born of moíhois treatod wilh Iho
highor doso (25 ~¡g/kg) displayed a desensilized responso
tu the acute cannabinoid challengo. Prolactin response
displayod sume subíle a¡íerations in tho ¡uwor-doso gruup,
although tboy only ciffected tho transient activalory effect
of cannabinoid in its socretion. ‘[he resulta observed in males
are consistent with proviously reported findings which roflecí
[bar early lito oxpeuiences, sucb as prenatal stress or perinatal
expusuro tu opiates, amphotamine, and cocaino, rnight
cunstituto a vulnerabiliíy factor fur drug abuse (Gallaghan
el al., 1994; Deminiéro et al., 1992; Gagin el al., 1997;
Kollor el al. 1996; Piazza & Le Moal, 1996).
An imbalance in the mesulimbic dupciminorgic network
has been considerod as tbe neuro-chemical basis of the
vulnerability tu psychostimulaní self-administraíion in rodents
(Piazza et al., 1989). As described aboye, matemal exposuro
tu cannabinoids not only results in developmontal a¡terations
uf [he dopaminergic systems in Ihe brain (Bonnin el al.,
1994; Rodríguez do Fonseca el al., 1990, 1991a, 1992a),
but lii permanení neuro-chemical alteratjoas in adulthoud
(García ot al. 1996; Navarro, de Miguel, Rodríguez de
Fonseca, Ramos, & Fernández-Ruiz, 1996; Navarro,
Rodríguez de Fonseca, Hernández, Ramos, & Fernández-
Ruiz, 1994a; Navarro, Rubio, & Rodríguez de Fonseca,
1995; Rubio el al., ¡995). lf we considor theso observatiuns
íogether wilh the data reflecting the alíeratiuns in the
bohaviural reactivity tu novelty and the response tu
morphine, as well as tho UPA a¡lorations, we can argue that
maternal exposure tu ‘[HG leads tu a vulnerable phenotype,
partially resembling thaI proposed fui amphotamine solf-
administration : mesucorticolimbic dupaminorgic altorations,
increasod behaviural responses tu nuvelty, and a sharp
adrencil response tu adaptivo challengos (Piazza et al., 1959,
1993, 1996). ‘[his propusod model uf vulnerabiliíy is depicted
in Figure 8. Further research is needod tu establish tu wbat
oxtent it can be also rolevaní for human species.
In Ibo animals oxpused tu low duses of ‘ERG, dio responso
tu Iho CPP íost was shiftod tu exhibit buth cm increased
sensitivity lo Ihe roinforcing propertios of an ED5<> dose of
murphino (resulting in a necir ¡00% positivo change of
preferonce in perinatal-exposed animals), and a clear nse In
plasma cuxticosterone levels, whicb wero positivoly correlalod.
Inlerestingly, prolactin responso tu tho GP? challenge was
nul corrolated with dio appearanco of cundilioning, although
it was clearly ciffectod by Ihe oxposure tu THG 20 mg/kg..
The polent and long-lasling adronal response tu acute RU-
210 exposure in animals born of muthers oxposed tu low
dusos of this cannabinoid is ci remarkable finding, sinco ibis
type of sonsitized HPA response has also boen proposod as
a factor underlying vulnorability tu psychustimulant self-
adminisíration (Maccari eí al., 1991). Soveral mechanistus
hayo been proposed in the elicitation of Iho perinatal effects
of cannabinuids (for reviow, seo Fernández-Ruiz el al. 1992
and Navarro ot al., 1995). ‘[hoy include changos in opioid
peptides ciad thoir recopturs (Kumar el al., ¡990), prenatal
stress-like offocts (Rubio el aí., 1995), direcí effects un
deveíuping monoaminergie systems (Bonnin et al., 1994;
Navarro el al., 1996; Rodríguez do Fonseca el al., 1991a;
Wal[ers & Can, 1956), and iho activation of brain cannabinoid
recoplois which are presont at birth (Rodríguez de Fonseca
el al., 1993). Bosidos tbe proviuusly describod actions of
cannabinoids un Ihe develuptuontal profile of dopaminergie
celís, a possible cannabinuid-ioduced develupmeotal alteratiun
in opioid peptides and tbeir receptors musí be considorod es
a factor underlying Ihe increased sonsitivity tu morphino-
induced place preferonce. It has boen proviously doscribed
thaI perinatal cannabinoid oxposuro can (a) alter Ihe
developmeníal expression of upioid peplidos in dio reí brain
(Kumar et al., 1990), and (b) induce changos in upiuid-related













Figure 8. Proposed model of vulnerability tu onvirunmental challengos induced by maternal expusure tu THC, Ihe pyschoactivo constiluení
of Cannabis sativa, in rodenís. THG exposure during crilical dove¡opmenlal poriods may resulí in permanení a¡teraíions in brain
structuro/funclion by oithor Ihe sílmulation of GB-l roceptors presení during Iho dovolopment, or tho alleraíions in maternal glucucorticoid
socretions, a known source of opigenetie-inducod dovelopmontal plasticily. Adulí challonges oither with drugs (i.e. opiales) or with
environmental strossors (i.e. nuvetty) will result in a modified paííern of neuro-chemical, endocrino, and bohavioral responses, leading
ultimalely lo inadaption and vulnerabilily.
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behaviors (Vela, Fuentes, Bonnin, Fernández-Ruiz, & Ruiz-
Gayo, 1995), namely a naloxone (5 mg/kg)-induced opioid-
liko abstinence syndromo in weanling males exposod tu tho
cannabinoid, aud dove¡upmontal alíeralions in bo[h pain
sonsilivity and the analgotie pruperties uf morphine.
Moreuver, íbero is a decir association betwoen ondogenous
opluid and cannabinuid systems in reward-related aroas,
supporting an important interaction in the modulatiun by Ihe
cannabinoid system of tho reinforcing properties of opicites
(Gardner & Luwinson, 1991).
The sexual dimorphism alroady reported, which has also
been obsorved in tho prosent sludy, is ci commun finding in
porinatal cannabinoid studies (Dalíerio and Baríke, 1979;
Fernández-Ruiz et al., 1992; Navarro el al., 1994b), and
might be reflocting Iho sex- dopondent developmental profile
uf bodi opiuid roceptors (Hammer, ¡985), and cannabinoid
receptors (Rodríguez de Fonseca et ‘al. 1993) in Ihe ral brain.
An additiunal explanatiun for tho effects described after
perinatal THG might be a possiblo cannabinoid-induced
súess-like effecí. ‘[bis prenatal stress-liko effect mighí occur
through a THC-induced activation of maternal HPA axis,
resulting in a riso of plasma-corticosterone lovels in Ihe
fetuses, which are dopondent un matornal levols (Ward &
Weisz, 1984; seo Figure 5). Howevor, this possibility must
still be conclusively detormined. Reconí studies (McCurmick,
Smytho, Sharma, & Moaney, ¡995; Valleé et al., 1997) hayo
describod how malernal-rostrainí stress resultod in a
permanont increase of basal corticusterone levels in Ihe adult
female offspring, which is tho same finding that wo hayo
observed afíer perinatal exposure lo ‘[HG. and which has
aÑo boen found after perinatal exposure tu alcohol in rals
(Lee & Rivier, 1996; ‘[aylur, Branch, Nelson, Fane, & Poland,
1986). Additiunally, pronalal síross has boen found tu alter
Ihe upioid contribution tu Iho bohavioral responso tu novel
environments (Poltyrov & Weinstuck. 1997). In any case, it
is worlhy uf note that the offecís of porinalal ‘[HG un
morphino sonsitivity and HPA activity may be independoní,
althuugh associatod in malo animais oxposed tu the luwor
dose of THG. It romains tu be determined whethor Iho
associatiun between morphino roinforcomen[ and HPA activily
is sexually dimorphic in naivo animals, ospocially if we
consider that tho studies which hayo set a role for
glucucordcoids un opiMo reinfurcement (seo Saham &
Stewart, 1995) hayo beon porformod unly wilh males, Other
gonder-rolatod findings aroso frum the present study: malo
rats bom of mothers oxposed tu ‘[HG (1 or Smg/kg) displayed
more expluratory behavior in the defonsive-withdrawal
paradigm, which might be considered tu resemble a female
pattern of behavior. Huwevor, they displayed a groaler
sensitivity tu the reinforcing proporties uf morphino than did
females from Ihe same experimental groups. In addition,
a¡though females also showod an altered response lo
morphino when compared tu controis, lhey did not display
an onhanced adronal response tu [be GPP testing but exhibited
permanently elovated basal levels uf corticosterune. These
dala suggost tha[ perinatal ‘[HG did nol resul[ either in
feminizaliun nor in masculinization of the behavioral and
endocrino parameters studied. We might conclude from Ihese
findings that [be proposed role of [be HPA in [be vulnerability
tu opiate reinforcoment is soxually dimorphic, and lhat
difforen[ial mechanisms may be undorlying ibis response in
both sexos.
‘[he surprising officacy of Iho low dusos of THC fur
eliciting long-torm behaviural altorcitions may be related tu
Ihe well-ducumen[ed biphasic actions uf’[HG (Dowey, ¡986)
and anandamide (Fride el al., 1995), which cummonly induce
uppusing cictions al low dusos (0.2 -2.0 mg/kg) when
cumpared lo higher unes (5-50 mg/kg). ‘[his has also boon
ubserved using anandamide, Ihe proposed endogenous ligand
fur the brain cannabinuid receptor (Frido & Mechoulam,
1996a, 1996b; Wonger, Fragkakis, Giannikou, & Yiannakis,
1997). In any case, we obsorved that uffspring of muthers
oxpusod tu ‘[HG 20 mg/kg, adoso tha[ is 10-20 times highor
than that estimatod for human cunsumplion of 2-3 marijuana
cigareties por day (Rosenkrmrtz el al., ¶975), did nol oxhibil
oilher ihe incroased sensitivity tu Ihe reinforcing proporties
of morphine nor tho altorod response tu novelty. Huwevor,
lhey did displciy altoralions in Iho locomotor activily (seo
Figures 2 cind 3), in accurdance witb proviuus studies
(Navarro et al., 1994a, ¡996). Regardless of ihe lack of
offecís obsorved in the GPP paradigm, it is importaní tu
remark that olher mechanisms, such as altoratiuns in the
ontugony of cannabinoid receptois, nutritional deficits, or
olher adaptivo prucesses may precludo the appoaranco of
Ihe effecls obsorved with tho lower dusos.
In surnmary, porinatal exposure tu ‘[HG doses relalod tu
human consumplion produced a clear shifí in the sensitivity
tu the roinforcing proportios uf murphino in malo offspring.
lnterestingly, rocent hypothosis atíribute tho onsel of drug
addicíion lo a drug-induced progrossive dysregulation of
homeosíatie procosses contrulling behaviural. nouru-chemical,
and ondocrine responses tu relevant external stimuli (Kuob
& Lo Mocil, ¡997). The fact thai cannabis consumption rnay
resulí in depondonce and addictiun (Rodríguez de Fonseca
el al., 1997) and that a recent roport has linked a particular
CB-l receptor gene albIo tu intravenuus use uf opiatos and
psychostimulants (Gomings ot al., 1997) pruvide further
suppurl tu [be nution of cannabinoid exposuro as a putential
vulnerabilily factor fur drug abuso.
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